Zachary D. Crees, MD¹, Michael P. Rettig, PhD², Reyka G. Jayasinghe, PhD^3*, Peter Ruminski, MS^4*, Abi Vainstein, MD^5*, Ella Sorani, PhD^6*, Allison A. King, MD, PhD, MPH⁷ and John F. DiPersio, MD, PhD⁸

¹Division of Oncology, Washington University School of Medicine, St. Louis, MO
²Division of Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, MO
³Department of Medicine, Washington University in St. Louis, St. Louis, MO
⁴Division of Oncology, Department of Medicine, Washington University School of Medicine, Wildwood, MO
⁵BioLineRx, Ltd., Modi'In, Israel
⁶BioLineRx Ltd., Modi'in, Israel
⁷Washington University School of Medicine, St. Louis, MO
⁸Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO

Patrick John Hayden, MD¹, Dirk-Jan Eikema^2*, Linda Koster^3*, John A Snowden⁴, Denis Caillot, MD^5*, Gwendolyn Van Gorkom, MD^6*, Laimonas Griskevicius, MD, PhD^7*, William Arcese, MD, PhD⁸, Charles Crawley⁹, Maurizio Musso^10*, Claude-Eric Bulabois, MD^11*, Alexander M Martin^12*, Tanja Netelenbos, MD, PhD¹³, Andrew McDonald, MD^14*, Johan Maertens^15*, Matteo Parma^16*, Arpad Illes, MD^17*, Cecilia Isaksson^18*, Claudia Sossa^19*, Joanna Drozd-Sokolowska^20*, Kavita Raj^21*, Meral Beksac^22*, Stefan Schönland^23,24*, Donal P. McLornan, MD, PhD^25* and Ibrahim Yakoub-Agha, MD, PhD²⁶

¹Department of Haematology, Trinity College Dublin, St. James's Hospital, Dublin 8, Leinster, Ireland
²EBMT Statistical Unit, Leiden, Netherlands
³EBMT Leiden Study Unit, Leiden, Netherlands
⁴Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom
⁵Centre Hospitalier Universitaire De Dijon, Hôpital Du Bocage, Dijon, France
⁶Dept. Internal Med.Hematology /Oncology, University Hospital Maastricht, Maastricht, Netherlands
⁷Department of Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius University, Vilnius, Lithuania
⁸Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
⁹Addenbrooke's Hospital, Cambridge, GBR
¹⁰Oncology Department, Hematology and Bone Marrow Transplant Unit, Ospedale La Maddalena, Palermo, Italy
¹¹Service d'Hématologie, CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble, France
¹²Leicester Royal Infirmary, Leicester, United Kingdom
¹³Hague Teaching Hospital, The Hague, Netherlands
¹⁴Alberts Cellular Therapy, Pretoria East Hospital, Pretoria, South Africa
¹⁵University Hospital Gasthuisberg, Leuven, Belgium
¹⁶Ospedale San Gerardo, Monza, Italy
¹⁷Department of Hematology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
¹⁸Umea University Hospital, Umeå, Sweden
¹⁹FOSCAL-UNAB, Floridablanca, Colombia
²⁰Central Clinical Hospital, The Medical University of Warsaw, Warsaw, Poland
²¹University College London Hospitals NHS Trust, London, United Kingdom
²²Ankara University, Ankara, Turkey
²³Department of Internal Medicine V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany
²⁴Medizinische Klinik V and Amyloidosis Center, Universitätsklinikum Heidelberg, Heidelberg, Germany
²⁵Haematology Department, University College London Hospitals NHS Foundation Trust, London, United Kingdom
²⁶Centre Hospitalier Universitaire de Lille LIRIC, INSERM U1286, Université de Lille, LILLE, France

Hal E. Broxmeyer, PhD¹, Larry L Luchsinger, PhD^2*, Rona S Weinberg, PhD², Alexandra Jimenez, MD^2*, Emeline Masson Frenet, PhD^2*, Mark Kaplan, PhD^1*, Scott Cooper, MS^1* and James Ropa, PhD¹

¹Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN
²New York Blood Center, New York, NY

Nina Worel, MD^1*, Per T Ljungman, MD, PhD^{2,3,4,5,6,7,8,9}, Isabel Sánchez-Ortega^10*, Jorinde D Hoogenboom^11*, Nina S Knelange^11,12*, Inge CM Verheggen^11*, Dirk-Jan Eikema^13*, Annalisa Ruggeri, MD, PhD^14*, Jurgen Kuball, MD¹⁵, Diana Averbuch, MD^16*, Rafael De La Camara, MD¹⁷ and Christian Chabannon, MD-PhD^18,19

¹Transfusion Medicine, Medical University Vienna, Vienna, Vienna, Austria
²Karolinska Comprehensive Cancer Center, Stockholm, Sweden
³Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden
⁴Department of Medicine, Huddinge, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden
⁵Karolinska University Hospital, Stockholm, Sweden
⁶Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
⁷Dept. of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, SWE
⁸Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital Huddinge, Div. of Hematology, Dept. of Medicine Huddinge, Karolinska Institutet,, Stockholm, Sweden
⁹Departments of Hematology and Cellular Therapy/Allogeneic Stem Cell Transplantation, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden
¹⁰EBMT Executive Office, Barcelona, Spain
¹¹EBMT Leiden Study Unit, Leiden, Netherlands
¹²EBMT Data Office, Leiden, Netherlands
¹³EBMT Statistical Unit, Leiden, Netherlands
¹⁴Hematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
¹⁵Department of Hematology, UMC Utrecht, Utrecht, Netherlands
¹⁶Pediatric Infectious Diseases, Hadassah Hebrew University Medical Center, Jerusalem, Israel
¹⁷Department of Hematology, Hospital Universitario de La Princesa, Madrid, Spain
¹⁸Institut Paoli Calmettes CLCC Provence-Alpes-Cote d'Azur, Marseille, France
¹⁹Cell Therapy Facility, Institut Paoli-Calmettes, Marseille, France

Samir Oza, MBS, BS^1*, Ronit Slotky, PhD, MSc^1*, Pranay Vissa, MD^2*, Pooja Phull, MD¹, Sukhdeep Kaur, MD^3*, Hyung C. Suh, MD, PhD^3*, Michele L. Donato, MD^4*, Scott D. Rowley, MD³, Noa Biran, MD⁵, David H. Vesole, MD, PhD⁶, David Samuel Siegel, MD, PhD⁷ and Harsh Parmar, MD^8*

¹John Theurer Cancer Center/Hackensack University Medical Center, Hackensack, NJ
²Hackensack Meridian School of Medicine, Nutley, NJ
³John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
⁴Stem Cell Transplantation and Cellular Therapy Program, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
⁵Hackensack Meridian Health John Theurer Cancer Center, Hackensack, NJ
⁶Myeloma Division, John Theurer Cancer Center at Hackensack Meridian Health, Hackensack, NJ
⁷John Theurer Cancer Center, Division of Multiple Myeloma, Hackensack University Medical Center, Hackensack, NJ
⁸Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack Meridian Health Network, Hackensack University Medical Center, Hackensack, NJ

Zachary M. Avigan, MD¹, Ajoy L. Dias, MD², Denise Cummings, RN, BSN, BMTCN^2* and Richard L. Haspel, MD, PhD³

¹Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
²Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
³Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

Erik Scott^1*, Dustin Strasburg^1*, Thomas Thompson, MD^2*, Christel Skaer, MLS(ASCP)^1*, Sarah Wittwer, MLS(ASCP)^1*, Margaret Diguardo, MD^1* and Eapen K. Jacob, MD³

¹Transfusion Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
²Transfusion Medicine, Department of Medicine and Pathology, Mayo Clinic, Jacksonville
³Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN